A series of DDW seminars based on the SLAS2026 theme of Catalyze Discovery will be available to visitors of the SLAS2026 International Conference and Exhibition (7-11 February 2026, Boston, USA).

The DDW ‘Creating cures: The role of lab automation in successful drug discovery’ programme will highlight innovative research using technology in drug development. It is sponsored by Gold Sponsors Collaborative Drug Discovery (CDD), Thermo Fisher Scientific and Brooks.

Renowned speakers from the pharmaceutical, biopharmaceutical and biotech industries will share insights into how technology is advancing drug discovery and development, and how this helps create cures.

The seminars will be held in The SLAS Ignite Theater on 9 and 10 February, located in the exhibition hall.

Seminars will be 30 mins in duration and will include high profile speakers from pharma and biotech highlighting the benefits of lab automation in fields such as AI, Lab Automation, Cell & Gene Therapy, CRISPR & Gene Editing, Therapeutics Antibodies, Synthetic Biology and more.

There will be a total of six seminars across the two days of the exhibition, covering:

  • How the discovery and development of new drugs starts with science, expertise and inspiration and how technology helps bring that to the patient
  • How lab automation is being used across academic and commercial life science research and aids new therapeutic and vaccine development
  • Using lab automation to make the journey from ideation to clinic with cost-efficiency and speed in mind
  • Future concepts for using lab automation technology successfully in the drug discovery process from lab to patient